U.S. Non-Glaucoma Ophthalmic Pharmaceuticals Market

U.S. Non-Glaucoma Ophthalmic Pharmaceuticals Market

 

RELEASE DATE
31-Dec-2008
REGION
North America
Research Code: N500-01-00-00-00
SKU: HC02102-NA-MR_07565
AvailableYesPDF Download

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC02102-NA-MR_07565

$4,950.00

$3,712.50save 25 %

DownloadLink
ENQUIRE NOW

Description

This research service explores the market for prescription ophthalmics used for the treatment of ocular diseases such as age-related macular degeneration (AMD), allergic conjunctivitis, chronic dry eye, cataract, and diabetic retinopathy in the United States of America. It analyzes the various challenges faced by pharmaceutical and biotech companies, and the competitive advantages and disadvantages of their products in the market.

Table of Contents

Research Scope and Methodology

  • Scope and Segmentation
  • Research Methodology

Market Overview

  • Introduction
  • Disease Overview

Patient Forecasts

  • Age-Related Macular Degeneration
  • Allergic Conjunctivitis
  • Chronic Dry Eye
  • NSAIDs
  • Diabetic Retinopathy

Market Trends

  • Industry Challenges and Strategies
  • Market Drivers

Approved Therapies and Treatment Trends

Pipeline Analysis

Related Research
This research service explores the market for prescription ophthalmics used for the treatment of ocular diseases such as age-related macular degeneration (AMD), allergic conjunctivitis, chronic dry eye, cataract, and diabetic retinopathy in the United States of America. It analyzes the various challenges faced by pharmaceutical and biotech companies, and the competitive advantages and disadvantages of their products in the market.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number N500-01-00-00-00
Is Prebook No